Cargando…

Metabolomic Profiling of Amino Acids in Human Plasma Distinguishes Diabetic Kidney Disease From Type 2 Diabetes Mellitus

Background: Diabetic kidney disease (DKD) is a highly prevalent complication in patients with type 2 diabetes mellitus (T2DM). Patients with DKD exhibit changes in plasma levels of amino acids (AAs) due to insulin resistance, reduced protein intake, and impaired renal transport of AAs. The role of A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Chunyu, Zhang, Qing, Lu, Liqian, Wang, Jiao, Liu, Dongwei, Liu, Zhangsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666657/ https://www.ncbi.nlm.nih.gov/pubmed/34912824 http://dx.doi.org/10.3389/fmed.2021.765873

Ejemplares similares

Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease
por: Wang, Jiao, et al.
Publicado: (2023)

Prediction and Risk Stratification of Cardiovascular Disease in Diabetic Kidney Disease Patients
por: Ren, Jingjing, et al.
Publicado: (2022)

Integration of Metabolomics and Proteomics in Exploring the Endothelial Dysfunction Mechanism Induced by Serum Exosomes From Diabetic Retinopathy and Diabetic Nephropathy Patients
por: Yang, Jing, et al.
Publicado: (2022)

Serum Total Bilirubin and Progression of Chronic Kidney Disease and Mortality: A Systematic Review and Meta-Analysis
por: Li, Jia, et al.
Publicado: (2021)

Diabetes Mellitus as a Risk Factor for Progression from Acute Kidney Injury to Acute Kidney Disease: A Specific Prediction Model
por: Zhao, Huanhuan, et al.
Publicado: (2021)

Plasma Targeted Metabolomics Analysis for Amino Acids and Acylcarnitines in Patients with Prediabetes, Type 2 Diabetes Mellitus, and Diabetic Vascular Complications
por: Li, Xin, et al.
Publicado: (2021)

Amino acid profiling in the gestational diabetes mellitus
por: Rahimi, Najmeh, et al.
Publicado: (2017)

Metabolomic Investigation of Blood and Urinary Amino Acids and Derivatives in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease
por: Mogos, Maria, et al.
Publicado: (2023)

Diabetic Nephropathy: Perspective on Extracellular Vesicles
por: Lu, Yanfang, et al.
Publicado: (2020)

Analysis of serum fatty acid, amino acid, and organic acid profiles in gestational hypertension and gestational diabetes mellitus via targeted metabolomics
por: Kong, Xiangju, et al.
Publicado: (2022)

Concise review: current trends on applications of stem cells in diabetic nephropathy
por: Liu, Dongwei, et al.
Publicado: (2020)

NLRP3-mediated pyroptosis in diabetic nephropathy
por: Wan, Jiayi, et al.
Publicado: (2022)

Plasma Amino Acids Metabolomics' Important in Glucose Management in Type 2 Diabetes
por: Alqudah, Abdelrahim, et al.
Publicado: (2021)

Plasma and Vitreous Metabolomics Profiling of Proliferative Diabetic Retinopathy
por: Wang, Hanying, et al.
Publicado: (2022)

The Interplay of Renin-Angiotensin System and Toll-Like Receptor 4 in the Inflammation of Diabetic Nephropathy
por: Feng, Qi, et al.
Publicado: (2020)

Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities
por: Wang, Hui, et al.
Publicado: (2023)

A Comprehensive Weighted Gene Co-expression Network Analysis Uncovers Potential Targets in Diabetic Kidney Disease
por: Pan, Shaokang, et al.
Publicado: (2023)

Plasma metabolomic profiling of proliferative diabetic retinopathy
por: Zhu, Xiao-Rong, et al.
Publicado: (2019)

Serum Metabolomics Benefits Discrimination Kidney Disease Development in Type 2 Diabetes Patients
por: Peng, Xiaofeng, et al.
Publicado: (2022)

Plasma Metabolomic Profiling of Patients with Diabetes-Associated Cognitive Decline
por: Zhang, Lin, et al.
Publicado: (2015)

Novel Biomarkers to Distinguish between Type 3c and Type 2 Diabetes Mellitus by Untargeted Metabolomics
por: Jimenez-Luna, Cristina, et al.
Publicado: (2020)

Broadening horizons: the contribution of mitochondria-associated endoplasmic reticulum membrane (MAM) dysfunction in diabetic kidney disease
por: Liu, Yong, et al.
Publicado: (2023)

Oatmeal in Diabetes Mellitus
Publicado: (1908)

Stem cells: a potential treatment option for kidney diseases
por: Liu, Dongwei, et al.
Publicado: (2020)

Characteristic changes in plasma glutamate levels and free amino acid profiles in Japanese patients with type 1 diabetes mellitus
por: Kawamori, Dan, et al.
Publicado: (2022)

Plasma-free amino acid profiles are predictors of cancer and diabetes development
por: Bi, X, et al.
Publicado: (2017)

Plasma Metabolomics Reveals Metabolic Profiling For Diabetic Retinopathy and Disease Progression
por: Sun, Yu, et al.
Publicado: (2021)

Gilbert’s Syndrome With Diabetes Mellitus
por: HAIXIA, LIU, et al.
Publicado: (2021)

Serum metabolomics detected by LDI‐TOF‐MS can be used to distinguish between diabetic patients with and without diabetic kidney disease
por: Qian, Fengmei, et al.
Publicado: (2023)

Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus
por: Zhu, Huanhuan, et al.
Publicado: (2022)

Design Flaws in the Study of Distinguishing Diabetes Associated With Chronic Pancreatitis and Type 2 Diabetes Mellitus
por: Liu, Yu, et al.
Publicado: (2019)

Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults
por: Bagheri, Minoo, et al.
Publicado: (2019)

Changes in Amino Acid and Acylcarnitine Plasma Profiles for Distinguishing Patients with Multiple Sclerosis from Healthy Controls
por: Kasakin, Marat F., et al.
Publicado: (2020)

Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey
por: Duan, Jiayu, et al.
Publicado: (2019)

Lysine Acetylation in the Proteome of Renal Tubular Epithelial Cells in Diabetic Nephropathy
por: Wan, Jiayi, et al.
Publicado: (2021)

Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study
por: Chevli, Parag Anilkumar, et al.
Publicado: (2021)

Urinary Metabolomic Profile of Neonates Born to Women with Gestational Diabetes Mellitus
por: Herrera-Van Oostdam, Ana Sofía, et al.
Publicado: (2021)

Differential Profile of Plasma Circular RNAs in Type 1 Diabetes Mellitus
por: Li, Yangyang, et al.
Publicado: (2020)

mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023)

The Expression of Tristetraprolin and Its Relationship with Urinary Proteins in Patients with Diabetic Nephropathy
por: Liu, Fengxun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4o1e5haroiqbccno51slj2mchp